FairScope Lab
EN 繁中 简中

MRNA

Valuation Healthcare · Biotechnology Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

-

PEG Ratio

-

Dividend Yield

-

Gross Margin

33.33%

Net Margin

-121.83%

Revenue CAGR 3Y

-49.13%

ROE

-38.20%

ROA

-26.78%

Buyback Yield

-0.51%

Current Ratio

3.29

Magic Earn Yield

-29.37%

Altman Z-Score

2.98

Fair Value River

Score

Valuation 0
Profitability 8
Growth 0
Health 80
Yield 0
← Back to Dashboard